Did Orexigen Risk Its Future To Boost Stock Price?
Obesity drug maker Orexigen Therapeutics OREX +32.12% disclosed this morning that early data from a study of its drug Contrave seem to show that not only does the medicine not cause heart attacks, as some feared, but that it may actually prevent them. That’s amazing news, and it sent Orexigen shares up 46% today.
Hey, check out all the research scientist jobs. Post your resume today!
Hey, check out all the research scientist jobs. Post your resume today!